Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tillis and Coons Bill Would Eliminate all Judicial Exceptions to Patent Eligibility
Eileen McDermott image
“If this bill passes it will nullify all Supreme Court precedent relating to patent eligibility, and specifically overrule Mayo, Myriad and Alice. The Federal Circuit and Supreme Court would need to start from scratch, and that would be a very good thing….” – Gene Quinn
EligibilityAs predicted by retired United States Court of Appeals for the Federal Circuit Chief Judge Paul Michel last month, Senators Chris Coons (D-DE) and Thom Tillis (R-NC) have introduced the first of what Michel said will be multiple bills aimed at fixing the U.S. patent system. Today’s bill, the Patent Eligibility Restoration Act of 2023, would eliminate all judicially-created exceptions to U.S. patent eligibility law.
Tillis first introduced the bill last August, and Coons announced he would co-sponsor the legislation in September 2022 at a Council for Innovation Promotion (C4IP) event. As part of today’s announcement, C4IP Co-Chairs and former U.S. Patent and Trademark Office (USPTO) Directors David Kappos and Andrei Iancu applauded the bill, calling it “much needed legislation to foster the development of next-generation technologies across many innovative industries, including artificial intelligence, medical diagnostics, quantum computing, and telecommunications, to name a few.”
The bill’s text articulates the following statutory exceptions to eligibility:
(D) The following inventions shall not be eligible for patent protection:
(i) A mathematical formula that is not part of an invention that is in a category described in subparagraph (B).
(ii) A mental process performed solely in the mind of a human being
(iii) An unmodified human gene, as that gene exists in the human body.
(iv) An unmodified natural material, as that material exists in nature.
(v) A process that is substantially economic, financial, business, social, cultural, or artistic.
With respect to the exception in paragraph (v), the text explains that “process claims drawn solely to the steps undertaken by human beings in methods of doing business, performing dance moves, offering marriage proposals, and the like shall not be eligible for patent coverage, and adding a non-essential reference to a computer by merely stating, for example, ‘’do it on a computer’ shall not establish such eligibility.”
Further, any process that requires the use of a machine, including a computer, to be performed, shall be eligible for patent protection under the bill.
The bill also repeatedly takes pains to distinguish Section 101 from Sections 102, 103 and 112.
Tillis said in the press release sent out today that the text strikes a balance between clarifying that the eligibility standard should be broad while also addressing concerns “by enumerating a specific but extensive list of excluded subject matter. “Passing patent eligibility reform remains one of my top legislative priorities during my second term,” Tillis said.
Coons said he was proud to join as a sponsor of the bill and that patent eligibility confusion has compromised the United States’ “competitive edge.”
“Critical technologies like medical diagnostics and artificial intelligence can be protected with patents in Europe and China, but not in the United States,” Coons said.
While the likelihood of the bill being passed remains unclear, Michel said in May that the mere introduction of such legislation could speed change along. He explained:
“The three biggest problems are all about to be the subject of bipartisan bills in the Senate, and the House will follow suit. I think when the bills are introduced and get cosponsored by numerous people of both parties, and then they start holding hearings, that will create a huge amount of momentum, and when the courts see the momentum, they will start acting on their own – particularly the Federal Circuit.”
IPWatchdog Founder and CEO Gene Quinn said the bill would be a welcome reset of the patent community:
“This bill would once and for all reassert Congressional authority to decide what is and what is not patentable, taking the legislative prerogative away from the Supreme Court. We all know the Supreme Court is not supposed to legislate, but for years the judicial exceptions to patentability— which by their very nature are extra-statutory— have been used to prevent the patenting of innovations that the law enacted by Congress allowed to be patented. If this bill passes it will nullify all Supreme Court precedent relating to patent eligibility, and specifically overrule Mayo, Myriad and Alice. The Federal Circuit and Supreme Court would need to start from scratch, and that would be a very good thing because the Supreme Court has painted the entire industry into a corner and they refuse to modify, elaborate or clarify their nonsensical approach to patent eligibility. It is far past time for a reset.”
IPWatchdog will share more commentary on the bill as we gather it.
Image Source: Deposit Photos
Author limbi007
209932054
SHARE
Come on LUDG Make some Noyce
Are you kidding, They can" stick their self with a pin.
The show is bullshit.
You are so right. So they say.
Man that commercial was the bomb, What happen?
Yes I do They couldn't even supply HSN.
How long have you been here Cart.
Big News is out.
Kay invented SEX. Not Trey Songz.
The show last night, was a BUMMER.
I guess They changed their mine on the new products. their getting very quite . What happen?.
It's Gonna Blow!!!
News out.
Michel Puts Hope in ‘Imminent’ Patent Bills Following SCOTUS Eligibility Denials
On day one of IPWatchdog’s Patent Litigation Masters program yesterday, the U.S. Supreme Court denied two patent eligibility cases that the U.S. Solicitor General had recommended granting. The denials make it fairly clear that the High Court is not interested in helping to resolve the current problems with U.S. patent eligibility law, which generally have to do with a lack of clarity, arguably fostered by many of the Court’s own precedents. Following the last panel of the day on Monday, in which speakers discussed ways to improve and streamline patent enforcement in America, retired U.S. Court of Appeals for the Federal Circuit Chief Judge Paul Michel told IPWatchdog he thinks the Supreme Court’s refusal to take up patent eligibility is self-serving. “I think the Court doesn’t want to admit they messed up the law in the four decisions – Bilski, Myriad, Mayo and Alice. They don’t even admit that it’s a big problem, but it is a huge problem, and everybody in the patent world knows it’s a huge problem,” Michel said.
Most of my tweeter is in Chinese's
ACCESSWIRE
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
Ludwig Enterprises Inc.
Wed, May 3, 2023 at 7:00 AM EDT
In this article:
LUDG
0.00%
Watchlist
Watchlist
SPARKS, NV / ACCESSWIRE / May 3, 2023 / Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - The Genomics Language Company™) is planning to expand its direct to consumer and direct to professional sales and marketing strategies to include individuals facing hair loss associated with inflammation.
Clinical researchers are studying the impact that inflammation, and the genomic biomarkers that regulate this process, could have on hair loss. mRNA biomarkers, TNF-a and CASP7, are overexpressed in moderate male and female pattern hair loss. Researchers have also emphasized the possible benefits associated with Niacin, Folic Acid, Vitamin E, and several B Vitamins as it relates to hair loss and healthy hair.
NuGenea™ is Ludwig Enterprise's ground-breaking nutraceutical that has been scientifically formulated to directly impact the mRNA biomarkers of inflammation including CASP7 and TNF-a. NuGenea's 20 ingredients also include those associated with healthy hair and the potential to support normal hair growth.
"I personally researched published scientific studies revealing the value of the 20 ingredients that are included in NuGenea's formula," said Dr. Marvin S. Hausman MD, its creator. "I found 84 scientific studies that demonstrated how these compounds have the potential to impact mRNA biomarkers of chronic inflammation, also called cytokines and chemokines, including those associated with male and female pattern hair loss."
"Approximately 80 million people in the US are suffering from hair loss," said Luke Fannon Ludwig's Chief Marketing Officer. "Hair loss significantly impacts self-esteem, and we believe that we can have a significant impact on lives of people who suffer from male and female pattern hair loss."
"Ludwig Enterprises plans on expanding our sales and marketing strategy to educate consumers about NuGenea's potential impact for hair loss sufferers," added Fannon. "We will also be working directly with trichologists and other salon professionals on bringing NuGenea to their clients."
NuGenea will be available direct to consumers via Ludwig's new website which will be launched shortly. For advanced orders consumers can send an email toNuGenea@ludg.us and request to be the first to receive this product. Healthcare professionals who want to discuss wholesale purchases of the product can call NuGenea's product launch department at 484-429-5846.
About Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. is a healthcare holding company focused on cutting edge mRNA genomic technology, therapeutics, and nutraceuticals. Through its subsidiary Precision Genomics, it has a patent pending on the mRNA Inflammatory Index™ that measures 48 different biomarkers of inflammation. Combined with AI and deep machine learning this technology may enable healthcare professionals to identify sources of chronic inflammation and potentially prevent chronic illnesses such as diabetes, COPD, heart disease and cancer. NuGenea™, a scientifically formulated nutraceutical, supported by decades of independent research into the anti-inflammatory properties of its compounds, is manufactured by the Ludwig subsidiary mRNAforLife, Inc.
Advancements in medical technology have awarded us with cutting-edge genomic tools, unheard of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era of medicine with their proprietary mRNA genomic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including, but not limited to heart disease, diabetes, preeclampsia, and cancer. This early detection may allow doctors to take steps to diagnose and manage illness before it progresses and causes serious health problems. Ludwig's innovative testing approach is not only practical but also has the potential to save the healthcare industry millions of dollars in costs. With a virtually untapped market and a billion-dollar healthcare industry, Ludwig and its subsidiaries Precision Genomics, Inc and mRNAforLife, Inc. are poised to significantly impact how we think about disease and live longer healthier lives. For more information please visit: http://www.ludwigent.com.
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
Zerify’s Cyber Security Solutions Featured in Aite-Novarica Group’s Quarterly Fintech Spotlight
ZRFY
-3.4483%
OTCM
0.00%
Zerify
Thu, April 27, 2023 at 7:57 AM EDT
In this article:
ZRFY
-3.4483%
Watchlist
Watchlist
OTCM
0.00%
Zerify
Zerify
Aite-Novarica analyst selects Zerify Defender as a product to watch
Report underscores Zerify’s unique approach to protect data amidst increased cyber threats
EDISON, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint Security announced today that the Aite-Novarica Group featured Zerify’s Meet and Zerify Defender in their Quarterly Fintech Spotlight report.
Aite-Novarica’s Risk Insights & Advisory Fintech Spotlight is a quarterly series of reports that looks at select emerging fintech vendors active in the fraud prevention, AML, and cybersecurity spaces. The vendor landscape is increasingly crowded, and their clients face a growing array of choices.
The Fintech Spotlight series aims to provide insight into interesting vendors that offer strong, unique selling points and innovative approaches as partners or competitors. The vendors are classified by the nature of their solutions’ functionality in fraud prevention, AML, and cybersecurity.
“We are extremely honored to be featured in Aite-Novarica’s prestigious Quarterly Fintech Spotlight report,” says Mark L. Kay, CEO of Zerify. “Aite-Novarica Group is an advisory firm providing mission-critical insights on technology, regulations, strategy, and operations to banks, insurers, payments providers, and investment firms.”
“The following report excerpt details why Aite-Novarica has positioned Zerify’s Meet & Defender as products to watch in this space,” says Kay:
Key Value Proposition and Market Challenges Addressed:
Zerify’s use of cutting-edge technology uniquely positions it to protect data in the era of remote work and increasing cyber threats. The following capabilities make Zerify a standout in the market:
Zero-trust architecture: Zerify eliminates an architectural gap in zero-trust deployments by requiring every user to authenticate video conferencing sessions.
Unique authentication options: Zerify Meet provides out-of-band and dial-in authentication.
Desktop lockdown: The Zerify agent locks down the camera, microphones, speakers, keyboards, and clipboards, preventing hacker and malware takeovers.
Meeting management: Zerify Meet provides comprehensive meeting management and reporting comparable to leading video conferencing platforms.
“One of most important points that is also listed in the Spotlight report is that traditional antivirus and endpoint solutions are designed to block known and documented threats. However, they leave the door open to new and emerging threats. Our Zerify Defender seals this gap and adds a layer of zero-trust protection, guarding businesses against both, known and unknown threats,” says Kay.
To learn more about Zerify products, go to: https://www.zerify.com/
About Aite-Novarica:
Aite-Novarica Group is an advisory firm providing mission-critical insights on technology, regulations, strategy, and operations to hundreds of banks, insurers, payments providers, and investment firms—as well as the technology and service providers that support them. Comprising former senior technology, strategy, and operations executives as well as experienced researchers and consultants, our experts provide actionable advice to our client base, leveraging deep insights developed via our extensive network of clients and other industry contacts. Visit us on the web and connect with us on Twitter and LinkedIn.
About Zerify:
Zerify Inc. (OTC PINK: ZRFY), formerly StrikeForce Technologies, is an Edison, New Jersey-based company with over two decades of experience in cybersecurity solutions. The company helps to prevent cyber theft and data security breaches for consumers, corporations and government agencies through powerful multi-factor “out-of-band” authentication and keystroke encryption along with mobile solutions. Zerify offers a video conferencing solution that uses no desktop and is entirely web-based, offering a five-level meeting security control approach designed to protect valuable information. Features include keystroke protection, anti-screen capture, and push and biometric authentication to keep businesses secure.
The technology also protects cameras, microphones and speakers, keeping computers and confidential data secure even when one is offline and not on a video conference. No other video conferencing service on the market, such as Zoom, Webex, LogMeIn, MS Teams or BlueJeans, offers these protections.
Zerify Contact,
Mark L. Kay
marklkay@zerify.com
(732) 661-9641
If the courts overturn OOB Then we Lic all the banks and who ever is using OOB, Major money would come back our way.
Killian Petitions Supreme Court to End Alice/Mayo
Jeffrey Killian yesterday submitted a petition for writ of certiorari to the United States Supreme Court asking the Court to provide clear guidance on or else throw out the Alice/Mayo test for patent eligibility. Killian is involved in an ongoing patent dispute in which the Patent Trial and Appeal Board (PTAB) rejected claims of his U.S. Patent Application No. 14/450,042 under Section 101. The U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed the ruling in August 2022. In the petition, Killian claims that the U.S. Patent and Trademark Office (USPTO) violated Supreme Court precedent by ruling the patent application ineligible under the Alice/Mayo test.
EDISON, N.J., April 25, 2023 (GLOBE NEWSWIRE) -- Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint Security announced today that Desktop Services Group, a leading provider of IT services, expanded their partnership with Zerify by adding two new products to their offerings: Zerify Defender Endpoint Security & Zerify Meet Secure Video Conferencing. These products will provide Desktop Services Group’s customers with enhanced security and privacy features for their businesses.
“We are excited to expand our partnership with Zerify by adding these two new products to our cyber offerings,” says Robert Newman, CEO of Desktop Services Group. “In today’s digital landscape, cybersecurity and privacy are more important than ever, and we believe that Zerify Defender and Zerify Meet will provide our customers with the peace of mind to conduct their business operations securely and confidently.”
“Zerify Defender is an Endpoint Security Agent which proactively locks down three devices (camera, microphone & audio-out speakers) and three processes (keyboard stack, clipboard and screen sharing) from attacks that most anti-virus and endpoint security solutions do not address. Traditional anti-virus and endpoint solutions were designed to block known and documented threats, but they leave the door open to new and emerging ones,” says Mark L Kay CEO of Zerify. “Defender compliments your existing solutions by sealing this gap, and protecting your business from known and unknown threats.”
“Zerify Meet is now considered the gold standard for Video Conferencing Security,” says Kay, “it’s the only Video Conferencing Platform on the market that authenticates every participant with two-factor authentication prior to joining a meeting. The platform encrypts all video and audio calls, ensuring that all conversations and data are secure and protected from potential cyber threats. The platform also includes features such as multi-screen sharing, virtual backgrounds, and chat capabilities to enhance the user experience.”
“Zerify’s commitment to providing cutting-edge technology solutions aligns with Desktop Services Group’s mission of providing its customers with the best technology solutions available. By adding Zerify Defender & Meet to their offering’s, Desktop Services Group is demonstrating their commitment to providing their customers with innovative, reliable, and secure solutions,” says Kay.
“We are thrilled to partner with the Desktop Services Group by providing them with our advanced endpoint security and video conferencing solutions,” says Kay. “Our products are designed to make businesses more efficient and secure and we are confident that our partnership with Desktop Services Group will help us achieve that goal.”
To learn more about Desktop Services Group, go to: https://www.dtsg.net/
To learn more about Zerify products, go to: https://www.zerify.com/
About Desktop Services Group:
Desktop Services Group's IT Solutions team helps clients succeed in today's changing digital environment. Our technology experts are experienced in all facets of Workstation, Server and Infrastructure support, and have the experience and know-how to get any job done right the first time.
24/7 Remote monitoring of equipment Update and Patch Management Managed Antivirus and EDR Cloud Backup and Business Continuity Network upgrades and installation IP Telephone systems Vulnerability scanning and analysis Dark Web monitoring DNS Filtering Security Awareness Training Password Management Services. We are proud of our reputation for Fast Service, Honesty & Integrity.
About Zerify:
Zerify Inc. (OTC PINK: ZRFY), formerly StrikeForce Technologies, is an Edison, New Jersey-based company with over two decades of experience in cybersecurity solutions. The company helps to prevent cyber theft and data security breaches for consumers, corporations and government agencies through powerful multi-factor “out-of-band” authentication and keystroke encryption along with mobile solutions. Zerify offers a video conferencing solution that uses no desktop and is entirely web-based, offering a five-level meeting security control approach designed to protect valuable information. Features include keystroke protection, anti-screen capture, and push and biometric authentication to keep businesses secure.
The technology also protects cameras, microphones and speakers, keeping computers and confidential data secure even when one is offline and not on a video conference. No other video conferencing service on the market, such as Zoom, Webex, LogMeIn, MS Teams or BlueJeans, offers these protections.
Zerify Contact,
Mark L. Kay
marklkay@zerify.com
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
LUDG
0.00%
Ludwig Enterprises Inc.
Tue, April 25, 2023 at 9:00 AM EDT
In this article:
LUDG
0.00%
Watchlist
Watchlist
SPARKS, NV / ACCESSWIRE / April 25, 2023 / Ludwig Enterprises, Inc., OTC:LUDG (Ludwig - The Genomics Language Company) has released its strategic sales and marketing plan as it launches its ground-breaking nutraceutical, NuGenea™. NuGenea, which means ‘New Life" in Greek, is a nutraceutical created by a physician and formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation.
"Chronic inflammation is a causative factor in illnesses such as cancer, diabetes, COPD and heart disease," said Dr. Marvin S. Hausman MD, NuGenea's creator. "The World Health Organization estimates that more than 50% of the world's deaths result from these illnesses. We believe NuGenea has the potential to improve the health of a large number of people."
"Ludwig's primary sales and marketing strategies for NuGenea will include Direct to Consumer and Direct to Healthcare Professionals," said Luke Fannon, Chief Marketing Officer. "The company's new ecommerce website will debut shortly, and consumers will be able to purchase the product directly. We are very excited to offer discounts for volume purchases and monthly product memberships."
NuGenea's direct to consumer strategy will include digital and traditional advertising, content and native marketing and placement in retail locations.
Integrative Medicine Professionals, which includes physicians, chiropractors, naturopathic physicians, and wellness clinics, will be a major focus for Ludwig's sales and marketing team according to Fannon. "This fast-growing branch of professionals believes in a holistic approach to their patient's care which includes lifestyle and diet changes, improvements in diets and usage of nutraceuticals," added Mr. Fannon.
Consumers interested in placing an advanced order for NuGenea can send an email toNuGenea@ludg.us and request to be the first to receive this product. Healthcare professionals who want to discuss wholesale purchases of the product can call NuGenea's product launch department at 484-429-5846.
About Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. is a healthcare holding company focused on cutting edge mRNA genomic technology, therapeutics, and nutraceuticals. Through its subsidiary Precision Genomics, it has a patent pending on the mRNA Inflammatory Index™ that measures 48 different biomarkers of inflammation. Combined with AI and machine learning this technology may enable healthcare professionals to identify sources of chronic inflammation and potentially prevent illnesses such as diabetes, COPD, heart disease and cancer. NuGenea™, a scientifically formulated nutraceutical, supported by decades of independent research into the anti-inflammatory properties of its compounds, is manufactured by the Ludwig subsidiary mRNAforLife, Inc and its My RNA for Life™ product line of nutraceuticals.
Advancements in medical technology have awarded us with cutting-edge genomic tools, unheard of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era of medicine with their proprietary mRNA genomic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including, but not limited to heart disease, diabetes, preeclampsia, and cancer. This early detection may allow doctors to take steps to diagnose and manage illness before it progresses and causes serious health problems. Ludwig's innovative testing approach is not only practical but also has the potential to save the healthcare industry millions of dollars in costs. With a virtually untapped market and a billion-dollar healthcare industry, Ludwig and its subsidiaries Precision Genomics, Inc and mRNAforLife, Inc. are poised to significantly impact how we think about disease and live longer healthier lives. For more information please visit: http://www.ludwigent.com.
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
Did I do that.
Yeah!
There is no doubt That they created OOB but the court said that they could not patent it.
you ever heard of OOB before they came out with it, nope.
So what can you say about OOB they created that and everyone is using it.
I would love to see them find it in Africa.
The Goju ryu Master
The GOJU Master.
ZRFY adds Chatgpt to its video chat, todays news on yahoo Fin.
Every month I buy LUDG.
Yahoo finc.
News Y Fin
News on yahoo f
News on TD just now.